Characteristics of Connective Tissue Diseases Interstitial Lung Diseases (CTD-ILD) Presenting in a Tertiary Care Hospital

Authors

  • Feroz Raza Author
  • Faisal Faiyaz Zuberi Author
  • Arif ul Islam Author
  • Asim Shafeeque Author

DOI:

https://doi.org/10.51985/JBUMDC2025757

Keywords:

Autoimmune Disorders; Connective Tissue Diseases; Interstitial Lung Diseases; Rheumatoid Arthritis; Systemic

Abstract

 bjective: To determine the characteristics of connective tissue diseases–interstitial lung diseases (CTD-ILD) presenting
in a tertiary care hospital.
Study design and setting: This descriptive cross-sectional study was conducted at the Department of Pulmonology, Ojha
Institute of Chest Disease, Dow University of Health Sciences, Karachi, from 11th February 2025 till 26th July 2025.
Methodology: For 6 months study patients aged 18–80 years diagnosed with ILD on the basis of clinical presentation and
radiological features were included. High-resolution computed tomography (HRCT) was performed to confirm ILD, while
connective tissue disease diagnoses were based on clinical criteria. Demographic data, clinical features, comorbidities, and
HRCT findings were recorded. Data were analyzed using SPSS version 25. Frequencies, percentages, and mean ± SD were
calculated. Chi-square test was applied for categorical variables with p = 0.05 considered significant.
Results: Among 54 CTD-ILD patients (mean age 51.9 ± 12.4 years, 70.4% females), rheumatoid arthritis (53.7%) was
the most common underlying disease. Honeycombing (87.0%) and septal thickening (75.9%) were the predominant HRCT
abnormalities. On stratified analysis, diabetes mellitus (p = 0.026) and smoking (p = 0.021) were more frequent in RAILD. Younger patients (18–40 years) more often had IPAF and SLE compared to older patients (p = 0.002).
Conclusion: RA was the main cause of CTD-ILD, with honeycombing and septal thickening as key HRCT patterns. CTDILD subtypes were significantly linked to diabetes, smoking, septal thickening, and age. 

References

1. Mogyoróssy S, Nagy-Vincze M, Griger Z, Dankó K, Szabó

Na, Szekanecz Z, Et Al. Novel Aspects Of Muscle Involvement

In Immune-Mediated Inflammatory Arthropathies And

Connective Tissue Diseases. Autoimmune Rev.

2023;22(5):103311. Doi: Https://Doi.Org/10.1016/ J.Autrev.

2023.103311.

2. Shi Y, Jiang N, Li M, Zeng X, Tian X. Mesenchymal Stem

Cells And Connective Tissue Diseases: From Bench To

Bedside. J Transl Int Med. 2022;11(1):30–45. Doi:

Https://Doi.Org/10.1515/Jtim-2022-0004.

3. Chan C, Ryerson Cj, Dunne Jv, Wilcox Pg. Demographic

And Clinical Predictors Of Progression And Mortality In

Connective Tissue Disease-Associated Interstitial Lung

Disease: A Retrospective Cohort Study. Bmc Pulm Med.

2019;19(1):192. Doi: Https://Doi.Org/10.1186/S12890-019-

0955-Y.

4. Shao T, Shi X, Yang S, Zhang W, Li X, Shu J, Et Al. Interstitial

Lung Disease In Connective Tissue Disease: A Common

Lesion With Heterogeneous Mechanisms And Treatment

Considerations. Front Immunol. 2021;12:684699. Doi:

Https://Doi.Org/10.3389/Fimmu.2021.684699.

5. Matson Sm, Demoruelle Mk. Connective Tissue DiseaseAssociated Interstitial Lung Disease. Immunol Allergy Clin

North Am. 2023;43(2):229–44. Doi: Https://Doi. Org/10.1016/

J.Iac.2023.01.003.

6. Cerro Chiang G, Parimon T. Understanding Interstitial Lung

Diseases Associated With Connective Tissue Disease (CtdIld): Genetics, Cellular Pathophysiology, And Biologic Drivers.

Int J Mol Sci. 2023;24(3):2405. Doi: Https://Doi.Org/

10.3390/Ijms24032405.

7. Yoo H, Hino T, Han J, Franks Tj, Im Y, Hatabu H, Et Al.

Connective Tissue Disease-Related Interstitial Lung Disease

(Ctd-Ild) And Interstitial Lung Abnormality (Ila): Evolving

Concept Of Ct Findings, Pathology And Management. Eur

J Radiol Open. 2020;8:100311. Doi: Https://Doi.Org/ 10.1016/

J.Ejro.2020.100311.

8. Atzeni F, Gerardi Mc, Barilaro G, Masala If, Benucci M,

Sarzi-Puttini P. Interstitial Lung Disease In Systemic

Autoimmune Rheumatic Diseases: A Comprehensive Review.

Expert Rev Clin Immunol. 2018;14(1):69–82. Doi:

Https://Doi.Org/10.1080/1744666x.2018.1411197

9. Mira-Avendaño I, Rivera F, Rojas C, Gómez D, Martínez P.

Interstitial Lung Disease In Systemic Sclerosis, Ra, Iim, Sle

And Mctd: Relative Frequencies Of Ct Imaging Patterns. Rev

Colomb Reumatol. 2024;31(1):45–53. Doi: Https://Doi.Org/

10.1016/J.Rcreu.2023.07.002.

10. Jepsen Y, Alarcon M, Klein U, Thomsen A. Practical Guidance

For Early Recognition And Follow-Up Of Patients With CtdIld. Clin Rheumatol. 2024;43(2):317–25. Doi:

Https://Doi.Org/10.1007/S10067-023-06584-Y.

11. Raghu G, Remy-Jardin M, Myers Jl, Richeldi L, Ryerson Cj,

Lederer Dj, Et Al. Diagnosis Of Idiopathic Pulmonary Fibrosis:

Ats/Ers/Jrs/Alat Guideline. Am J Respir Crit Care Med.

2018;198(5):E44–68. Doi: Https://Doi.Org/ 10.1164/

Rccm.201807-1255st.

12. Jayasinghe P, Wickramasinghe N, Krishnakumar P, Sadikeen

A, Fernando A. Characteristics Of Connective Tissue Diseases

Associated Interstitial Lung Diseases – A Single Centre Study

In Sri Lanka. Ceylon Med J. 2021;66(1):38–43. Doi:

Https://Doi.Org/10.4038/Cmj.V66i1.9405.

13. Antoniou Km, Margaritopoulos Ga, Goh Ns, Hansell Dm,

Nicholson Ag. Honeycombing In Usual Interstitial Pneumonia:

Prognostic Significance. Eur Respir J. 2016;48(5):1518–28.

Doi: Https://Doi.Org/10.1183/13993003.01082-2016.

14. Kim Ej, Elicker Bm, Maldonado F, Webb Wr, Ryu Jh, Van

Uden Jh, Et Al. Usual Interstitial Pneumonia In Rheumatoid

Arthritis-Associated Ild. Arthritis Res Ther. 2010;12(2):R79.

Doi: Https://Doi.Org/10.1186/Ar2987.

15. Yoo H, Hino T, Han J, Franks Tj, Im Y, Hatabu H, Et Al.

Connective Tissue Disease-Related Interstitial Lung Disease

And Interstitial Lung Abnormality: Evolving Concepts Of Ct

Findings, Pathology, And Management. Eur J Radiol Open.

2020;8:100311. Doi: Https://Doi.Org/10.1016/ J.Ejro.2020

.100311.

16. Wells Au, Denton Cp. Interstitial Lung Disease In Systemic

Sclerosis: Nsip Vs Uip. Rheumatology (Oxford). 2014;53(9):

1612–21. Doi: Https://Doi.Org/10.1093/ Rheumatology/

Keu165.

17. Kelly Ca, Saravanan V, Nisar M, Arthanari S, Woodhead Fa,

Price-Forbes An, Et Al. Rheumatoid Arthritis-Related

Interstitial Lung Disease: Associations With Diabetes And

Other Comorbidities. Ann Rheum Dis. 2014;73(8):1511–9.

Doi: Https://Doi.Org/10.1136/Annrheumdis-2012-203160.

18. Sparks Ja, Chang Sc, Liao Kp, Costenbader Kh, Karlson Ew.

Associations Of Smoking And Rheumatoid Arthritis-Related

Interstitial Lung Disease Risk. Arthritis Care Res (Hoboken).

2019;71(2):187–95. Doi: Https://Doi.Org/10.1002/Acr.23782.

19. Iqbal K, Kelly C. Interaction Of Smoking And Anti-Ccp In

Rheumatoid Arthritis-Associated Ild. Rheumatology (Oxford).

2021;60(1):104–12. Doi: Https://Doi.Org/10.1093/

Rheumatology/Keaa223.

20. Singh N, Varghese J, Verma S, Agarwal V, Misra R. Interstitial

Lung Disease In Systemic Lupus Erythematosus: Clinical

Spectrum And Prognosis. Lupus. 2016;25(9):960–8. Doi:

Https://Doi.Org/10.1177/0961203315622824.

21. Assayag D, Kim Ej, Elicker Bm, Collard Hr, King Te Jr.

Survival Trends In Connective Tissue Disease-Related

Interstitial Lung Disease: Influence Of Hrct Pattern. Chest.

2014;146(3):633–40

Downloads

Published

2026-01-14

Issue

Section

Original Articles

Similar Articles

1-10 of 18

You may also start an advanced similarity search for this article.